Deutsche Bank Aktiengesellschaft Has Lowered Expectations for UnitedHealth Group (NYSE:UNH) Stock Price

UnitedHealth Group (NYSE:UNH) had its price target reduced by Deutsche Bank Aktiengesellschaft from $521.00 to $362.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of 32.14% from the company’s current price.

A number of other analysts have also recently weighed in on the stock. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Bank of America lowered shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $560.00 to $350.00 in a report on Wednesday. HSBC restated a “hold” rating and issued a $490.00 target price on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Mizuho increased their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. Six investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $508.38.

UnitedHealth Group Trading Down 11.1%

Shares of NYSE:UNH opened at $273.96 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a 50-day simple moving average of $474.72 and a 200 day simple moving average of $515.82. The company has a market capitalization of $248.52 billion, a P/E ratio of 17.67, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 earnings per share. Sell-side analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current year.

Institutional Trading of UnitedHealth Group

Large investors have recently added to or reduced their stakes in the stock. Financial Management Professionals Inc. raised its holdings in UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after buying an additional 17 shares during the period. Western Pacific Wealth Management LP raised its holdings in UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after buying an additional 19 shares during the period. MCF Advisors LLC raised its holdings in UnitedHealth Group by 0.8% in the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after buying an additional 20 shares during the period. Axiom Financial Strategies LLC raised its stake in shares of UnitedHealth Group by 3.6% during the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock valued at $291,000 after purchasing an additional 20 shares during the period. Finally, Richwood Investment Advisors LLC raised its stake in shares of UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after purchasing an additional 20 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.